| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,639 |
19,169 |
$1.04M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
8,772 |
8,457 |
$600K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,655 |
3,163 |
$139K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16,628 |
15,088 |
$127K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,974 |
3,210 |
$101K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,990 |
3,131 |
$47K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,347 |
2,856 |
$35K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
570 |
553 |
$26K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
999 |
780 |
$21K |
| S9083 |
Global fee urgent care centers |
211 |
123 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
426 |
303 |
$15K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,000 |
972 |
$13K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
417 |
394 |
$12K |
| 90674 |
|
527 |
526 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
402 |
289 |
$9K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
398 |
304 |
$6K |
| 90715 |
|
110 |
110 |
$5K |
| 90756 |
|
123 |
115 |
$2K |
| 90686 |
|
166 |
162 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,133 |
1,031 |
$2K |
| 87070 |
|
104 |
94 |
$296.83 |
| 87184 |
|
100 |
93 |
$278.81 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
29 |
29 |
$173.04 |
| 81002 |
|
93 |
89 |
$109.63 |
| 90688 |
|
13 |
13 |
$90.59 |
| 86580 |
|
14 |
13 |
$42.94 |